Rohit Bhargava leads development of hybrid microscope that could bring digital biopsy to the clinic
By adding infrared capability to the ubiquitous, standard optical microscope, researchers at the University of Illinois at Urbana-Champaign hope to bring cancer diagnosis into the digital era.
Pairing infrared measurements with high-resolution optical images and machine learning algorithms, the researchers created digital biopsies that closely correlated with traditional pathology techniques and also outperformed state-of-the-art infrared microscopes.
Led by Rohit Bhargava, a Founder Professor in Bioengineering and director of the Cancer Center at Illinois, the group published its results in February in the Proceedings of the National Academy of Sciences.
“The advantage is that no stains are required, and both the organization of cells and their chemistry can be measured," Bhargava said. "Measuring the chemistry of tumor cells and their microenvironment can lead to better cancer diagnoses and better understanding of the disease.”
The current gold standard of tissue pathology is to add dyes or stains so pathologists can see the shapes and patterns of the cells under a microscope. However, it can be difficult to distinguish cancer from healthy tissue or to pinpoint the boundaries of a tumor, and in many cases diagnosis is subjective.
“For more than a century, we have relied on adding dyes to human tissue biopsies to diagnose tumors. However, the shape and color induced by the dye provide very limited information about the underlying molecular changes that drive cancer,” Bhargava said.
Technologies like infrared microscopy can measure the molecular composition of tissue, providing quantitative measures that can distinguish cell types. Unfortunately, infrared microscopes are expensive and the samples require special preparation and handling, making them impractical for the vast majority of clinical and research settings.
Bhargava’s group developed its hybrid microscope by adding an infrared laser and a specialized microscope lens, called an interference objective, to an optical camera. The infrared-optical hybrid measures both infrared data and a high-resolution optical image with a light microscope – the kind ubiquitous in clinics and labs.
“We built the hybrid microscope from off-the-shelf components. This is important, because it allows others to easily build their own microscope or upgrade an existing microscope,” said Martin Schnell, a Marie Curie Postdoctoral Fellow in Bhargava’s group and first author of the paper.
Combining the two techniques harnesses the strengths of both, the researchers said. It has the high resolution, large field-of-view, and accessibility of an optical microscope. Furthermore, infrared data can be analyzed computationally, without adding any dyes or stains that can damage tissues. Software can recreate different stains or even overlap them to create a more complete, all-digital picture of what is in the tissue.
The team verified its microscope by imaging breast tissue samples, both healthy and cancerous, and comparing the results of the hybrid microscope’s computed “dyes” with those from the traditional staining technique. The digital biopsy closely correlated with the traditional one.
Furthermore, the researchers found that their infrared-optical hybrid outperformed current infrared microscopes in several ways: It has 10 times larger coverage, greater consistency, and four times higher resolution, allowing infrared imaging of larger samples, in less time, and with unprecedented detail.
“Infrared-optical hybrid microscopy is widely compatible with conventional microscopy in biomedical applications,” Schnell said. “We combine the ease of use and universal availability of optical microscopy with the wide palette of infrared molecular contrast and machine learning. And by doing so, we hope to change how we routinely handle, image, and understand microscopic tissue structure.”
The researchers plan to continue refining the computational tools used to analyze the hybrid images. They are working to optimize machine-learning programs that can measure multiple infrared wavelengths — creating images that readily distinguish between multiple cell types — and integrate that data with the detailed optical images to precisely map cancer within a sample. They also plan to explore further applications for hybrid microscope imaging, such as forensics, polymer science, and other biomedical applications.
“It is very intriguing what this additional detail can offer in terms of pathology diagnoses,” Bhargava said. “This could help speed up the wait for results, reduce costs of reagents and people to stain tissue, and provide an ‘all-digital’ solution for cancer pathology.”
The National Institutes of Health supported this work. Bhargava also is affiliated with the Beckman Institute for Advanced Science and Technology and the Carle Illinois College of Medicine.
The researchers' article is online at: www.pnas.org/content/117/7/3388 .